ZNF594
gene geneOn this page
Also known as KIAA1871
Summary
ZNF594 (zinc finger protein 594, HGNC:29392) is a protein-coding gene on chromosome 17p13.2, encoding Zinc finger protein 594 (Q96JF6). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm.
Source: NCBI Gene 84622 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 151 total
- MANE Select transcript:
NM_032530
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29392 |
| Approved symbol | ZNF594 |
| Name | zinc finger protein 594 |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1871 |
| Ensembl gene | ENSG00000180626 |
| Ensembl biotype | protein_coding |
| Entrez | 84622 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000399604, ENST00000575779, ENST00000576772, ENST00000851805
RefSeq mRNA: 1 — MANE Select: NM_032530
NM_032530
CCDS: CCDS42241
Canonical transcript exons
ENST00000575779 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001539307 | 5191748 | 5191868 |
| ENSE00002658659 | 5179535 | 5184276 |
Expression profiles
Bgee: expression breadth ubiquitous, 186 present calls, max score 81.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8601 / max 39.6096, expressed in 1377 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164020 | 3.8601 | 1377 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 81.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.75 | gold quality |
| ventricular zone | UBERON:0003053 | 80.68 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.29 | gold quality |
| sural nerve | UBERON:0015488 | 79.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.31 | gold quality |
| left ovary | UBERON:0002119 | 76.35 | gold quality |
| right ovary | UBERON:0002118 | 75.55 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.54 | gold quality |
| right uterine tube | UBERON:0001302 | 74.94 | gold quality |
| ovary | UBERON:0000992 | 74.89 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 74.41 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 74.19 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 74.11 | gold quality |
| cerebellar cortex | UBERON:0002129 | 74.00 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.95 | gold quality |
| pituitary gland | UBERON:0000007 | 73.90 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.76 | gold quality |
| muscle of leg | UBERON:0001383 | 73.49 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.42 | gold quality |
| body of uterus | UBERON:0009853 | 73.26 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 73.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.04 | gold quality |
| thyroid gland | UBERON:0002046 | 72.97 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.93 | gold quality |
| vermiform appendix | UBERON:0001154 | 72.91 | gold quality |
| cerebellum | UBERON:0002037 | 72.75 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 72.45 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 72.44 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8060 | yes | 299.62 |
| E-MTAB-6058 | no | 40.68 |
| E-ANND-3 | no | 2.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
113 targeting ZNF594, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| drosophila_melanogaster | mld | FBGN0263490 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 594 — Q96JF6 (reviewed: Q96JF6)
Alternative names: Zinc finger protein HZF18
All UniProt accessions (2): Q96JF6, I3L508
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_115919* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (29 total): zinc finger region 24, sequence variant 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96JF6-F1 | 69.26 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, HES2_TARGET_GENES, HHEX_TARGET_GENES, RBM34_TARGET_GENES, SNIP1_TARGET_GENES, ZNF524_TARGET_GENES, MIR4262, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P, MIR6833_3P, MIR4492
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
476 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF594 | CAPN15 | O75808 | 535 |
| ZNF594 | MED8 | Q96G25 | 479 |
| ZNF594 | ETV7 | Q9Y603 | 462 |
| ZNF594 | RNF157 | Q96PX1 | 447 |
| ZNF594 | TFB2M | Q9H5Q4 | 443 |
| ZNF594 | ZNF236 | Q9UL36 | 417 |
| ZNF594 | PPAN | Q9NQ55 | 398 |
| ZNF594 | DOT1L | Q8TEK3 | 390 |
| ZNF594 | MAMLD1 | Q13495 | 386 |
| ZNF594 | FRG2C | A6NGY1 | 370 |
| ZNF594 | A0A0B4J1V8 | A0A0B4J1V8 | 364 |
| ZNF594 | ZNF862 | O60290 | 352 |
| ZNF594 | MSH3 | P20585 | 350 |
| ZNF594 | C2CD4C | Q8TF44 | 349 |
| ZNF594 | EPHB2 | P29323 | 349 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF594 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ANKRD36B | CCDC66 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| FMR1 | ZNF594 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF594 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZNF594 (Affinity Capture-MS), GOLGA2 (Two-hybrid), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
151 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 136 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
84 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:5184161:ACATT:A | donor_gain | 0.9600 |
| 17:5184162:CATTC:C | donor_gain | 0.9600 |
| 17:5184165:T:A | donor_gain | 0.9600 |
| 17:5184161:A:AC | donor_gain | 0.8600 |
| 17:5184162:C:CC | donor_gain | 0.8600 |
| 17:5184157:A:AC | donor_gain | 0.8200 |
| 17:5184158:C:CC | donor_gain | 0.8200 |
| 17:5184162:CATT:C | donor_gain | 0.8000 |
| 17:5183142:T:TA | donor_gain | 0.6800 |
| 17:5184214:T:TA | donor_gain | 0.6200 |
| 17:5184163:A:C | donor_gain | 0.5900 |
| 17:5184382:C:A | donor_gain | 0.5800 |
| 17:5184156:A:T | donor_gain | 0.5300 |
| 17:5184381:T:A | donor_gain | 0.5300 |
| 17:5183657:T:TA | donor_gain | 0.5200 |
| 17:5184156:A:AT | donor_gain | 0.4900 |
| 17:5183654:ATGT:A | donor_gain | 0.4700 |
| 17:5183801:ATTT:A | donor_gain | 0.4100 |
| 17:5184158:CTCA:C | donor_gain | 0.4100 |
| 17:5184155:TAAC:T | donor_gain | 0.4000 |
| 17:5184155:TA:T | donor_gain | 0.3600 |
| 17:5184158:C:G | donor_gain | 0.3600 |
| 17:5184113:CCAG:C | donor_gain | 0.3500 |
| 17:5184155:TAA:T | donor_loss | 0.3500 |
| 17:5184156:AACT:A | donor_loss | 0.3500 |
| 17:5184157:A:T | donor_loss | 0.3500 |
| 17:5184158:C:CA | donor_loss | 0.3500 |
| 17:5184159:T:TC | donor_gain | 0.3500 |
| 17:5184159:TCACA:T | donor_loss | 0.3500 |
| 17:5184160:C:CC | donor_gain | 0.3500 |
AlphaMissense
5446 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:5182850:A:C | F469L | 0.997 |
| 17:5182850:A:T | F469L | 0.997 |
| 17:5182852:A:G | F469L | 0.997 |
| 17:5182274:G:C | F661L | 0.996 |
| 17:5182274:G:T | F661L | 0.996 |
| 17:5182276:A:G | F661L | 0.996 |
| 17:5182766:G:C | F497L | 0.994 |
| 17:5182766:G:T | F497L | 0.994 |
| 17:5182768:A:G | F497L | 0.994 |
| 17:5183018:G:C | F413L | 0.993 |
| 17:5183018:G:T | F413L | 0.993 |
| 17:5183020:A:G | F413L | 0.993 |
| 17:5182190:G:C | F689L | 0.992 |
| 17:5182190:G:T | F689L | 0.992 |
| 17:5182192:A:G | F689L | 0.992 |
| 17:5182934:A:C | F441L | 0.992 |
| 17:5182934:A:T | F441L | 0.992 |
| 17:5182936:A:G | F441L | 0.992 |
| 17:5182326:C:G | R644P | 0.991 |
| 17:5183001:A:G | L419P | 0.991 |
| 17:5182902:C:G | R452P | 0.990 |
| 17:5182917:A:G | L447P | 0.990 |
| 17:5182442:G:C | F605L | 0.989 |
| 17:5182442:G:T | F605L | 0.989 |
| 17:5182444:A:G | F605L | 0.989 |
| 17:5182358:A:C | F633L | 0.988 |
| 17:5182358:A:T | F633L | 0.988 |
| 17:5182360:A:G | F633L | 0.988 |
| 17:5182823:G:C | H478Q | 0.988 |
| 17:5182823:G:T | H478Q | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000264797 (17:5186237 G>A,C), RS1000471323 (17:5191959 C>T), RS1000574711 (17:5187326 A>G), RS1000605931 (17:5187080 T>A), RS1000719030 (17:5177197 T>A), RS1000767162 (17:5179550 T>A,C), RS1000837558 (17:5175434 A>T), RS1001002256 (17:5193752 A>G), RS1001038827 (17:5180609 G>C), RS1001074231 (17:5193312 C>A,T), RS1001088811 (17:5186488 C>T), RS1001137032 (17:5179860 A>G), RS1001361065 (17:5179571 A>G), RS1001370846 (17:5179280 G>A), RS1001494822 (17:5189103 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, affects expression, increases abundance | 3 |
| Valproic Acid | affects expression, increases expression | 3 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression, decreases expression | 2 |
| Arsenic | affects methylation, affects cotreatment, increases abundance, increases expression | 2 |
| Cyclosporine | decreases expression, increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| ferrous chloride | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| pentabromodiphenyl ether | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Zinc | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.